Loading...
Loading...
Application UK00912533469 · Dead
| Application Number | UK00912533469 |
| Status | Dead |
| Owner | Samsung Bioepis Co., Ltd. |
| Filed | 2014-01-24 |
| Registered | 2014-06-05 |
| Renewal Due | 2024-01-24 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
ENSEF has a current status of Dead.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis.
'ENSEF' is a dead trademark on the UK IPO register, owned by Samsung Bioepis Co., Ltd.. The application (UK00912533469) was filed on 24 January 2014 and registered on 5 June 2014. The registration is set to expire on 24 January 2024.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by ip21 Limited.
UK trademark UK00912533469 for the mark 'ENSEF' in Class 5 is recorded on the UK IPO register as owned by Samsung Bioepis Co., Ltd.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the UK IPO records the status of UK trademark UK00912533469 for the mark 'ENSEF' as dead.
UK trademark UK00912533469 for the mark 'ENSEF' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical preparations; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharma…
UK trademark UK00912533469 for the mark 'ENSEF' was filed at the UK IPO on 24 January 2014 and registered on 5 June 2014.
UK trademark UK00912533469 for the mark 'ENSEF' is currently recorded as valid until 24 January 2024, at which point it will need to be renewed with the UK IPO to remain in force.
ip21 Limited is listed as the attorney / representative of record for UK trademark UK00912533469 for the mark 'ENSEF' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "ENSEF" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| ENSEFSame applicant | 87351128 | 710 | 2017-02-27 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.